Hydroxyl radical and related cytotoxic reactive species (ROS)

Hydroxyl radicals and related cytotoxic reactive species, collectively known as reactive oxygen species (ROS), are highly unstable oxygen-containing molecules that possess unpaired electrons. They are primarily generated within the mitochondria during aerobic respiration or by enzymes such as NADPH oxidase during immune responses (StatPearls, 2023, NBK535454). While low levels of ROS are essential for intracellular signaling and the destruction of pathogens, excessive accumulation leads to oxidative stress, which irreversibly damages DNA, lipids, and proteins (PubMed, PMID: 28249118). This oxidative damage is a critical driver in the pathogenesis of neurodegenerative disorders like Amyotrophic Lateral Sclerosis (ALS), cardiovascular diseases, and various cancers (NIH, 2022). Therapeutic intervention typically involves the use of antioxidant scavengers, such as Edaravone or N-acetylcysteine, which neutralize these species to prevent cellular death and tissue degradation (PubChem, CID 4011). These drugs act by donating electrons to stabilize the radicals or by enhancing the endogenous antioxidant defense systems (PubMed, PMID: 28831557). However, the clinical application of ROS scavengers is often challenged by the need to maintain a delicate redox balance, as complete suppression of ROS can interfere with vital homeostatic signaling pathways (PubMed, PMID: 30585954). Furthermore, the high reactivity and short half-life of species like the hydroxyl radical make targeted delivery of scavengers to the site of injury a significant pharmacological hurdle.

Other names

Reactive oxygen speciesFree radicalsHydroxyl radicalSuperoxide anionHydrogen peroxideSinglet oxygenReactive nitrogen species

Free radical scavenging, neutralization of reactive oxygen species, and induction of endogenous antioxidant enzymes.